[Clinical usefulness of ondansetron injection in patients receiving cancer chemotherapy].

Author: FujiiTsuneo, FurueHisashi, IkedaMasanori, RikimaruToru, TaguchiTetsuo, TsukagoshiShigeru

Paper Details 
Original Abstract of the Article :
Before and after launch of 5-HT3, antagonist, necessary dose and duration of chemotherapy were compared between the patients who were confirmed to have undergone chemotherapy before the launch of 5-HT3 antagonist (retrospective group) and the ones currently using ondansetron (OND) for chemotherapy-i...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/11865633

データ提供:米国国立医学図書館(NLM)

Clinical Usefulness of Ondansetron Injection in Patients Receiving Cancer Chemotherapy

Chemotherapy-induced nausea and vomiting (CINV) is a distressing side effect of cancer treatment. This study examines the clinical usefulness of ondansetron, a 5-HT3 receptor antagonist, in managing CINV. The researchers compared the necessary dose and duration of chemotherapy between patients who received chemotherapy before the availability of ondansetron and those who currently use ondansetron for CINV. They also conducted a survey on quality of life (QOL) and questionnaires to assess the impact of ondansetron on patient and medical staff experiences.

Ondansetron: Improving Patient QOL and Reducing Workload

The study found that ondansetron significantly improved patient QOL and reduced the workload of medical staff. While ondansetron did not directly influence the necessary dose or duration of chemotherapy, it did have a positive impact on managing CINV and reducing the occurrence of adverse events such as blood disorders and renal dysfunction. This, in turn, allowed patients to receive their chemotherapy regimen more effectively.

Optimizing Cancer Treatment

This research underscores the importance of effective antiemetic control in cancer treatment. Ondansetron has proven to be a valuable tool in managing CINV, improving patient QOL and streamlining the chemotherapy process. This research highlights the significant impact of managing side effects on patient outcomes and healthcare efficiency.

Dr.Camel's Conclusion

Just as a camel can navigate harsh desert conditions by seeking shade and water, ondansetron provides a much-needed respite from the unpleasant side effects of chemotherapy. This research highlights the importance of effective symptom management in improving patient well-being and optimizing cancer treatment.

Date :
  1. Date Completed 2002-03-05
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

11865633

DOI: Digital Object Identifier

11865633

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.